Experts think certain non-routine tests are worth asking your doctor about, since the results could point to health-saving ...
Three patients with light chain amyloidosis have been treated with CAR T cell therapy in the first European clinical trial testing the safety and efficacy of this immunotherapy in this patient group, ...
12don MSN
Puffy eyes that won’t go away? Why it could signal kidney trouble, and when to get tested
Persistent under-eye puffiness, even after good sleep, may be more than a cosmetic concern. It can reflect fluid imbalance ...
Preeclampsia complicates 3 to 8 percent of pregnancies. In a recent trial, a blood filter lowered blood pressure and helped ...
Do you wake up with puffy eyes every morning? It's time you paid heed to the root cause of under-eye puffiness. Expert lists ...
As global cancer cases continue to rise, this may be the breakthrough in cancer research we’ve all been hoping for.
A new scan detects endometriosis without surgery and could speed up the diagnosis of this painful and common condition ...
Mid-Day on MSN
Can Mumbai rats spread hantavirus?
As a deadly hantavirus outbreak aboard the MV Hondius cruise ship leaves three dead and at least five infected, there is one question worrying Mumbaikars: could this rare rodent-borne virus ever reach ...
A study has raised concerns about a widely used cholesterol-lowering medicine, suggesting that it may increase the risk of ...
A new urine test performed better than PSA-based testing and MRI for monitoring low-risk prostate cancers on active ...
April 21 (Reuters) - AstraZeneca said on Tuesday its rare blood disorder drug Ultomiris has met the main goal of a late-stage trial, showing a reduction in protein found in the urine of patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results